The value of transparency is not limited to public agencies and governmental affairs.

This article analyses the root cause of soaring pharmaceutical costs and lays the blame squarely at the feet of pharmacy benefit managers who secretly negotiate between drug companies and health insurers.

Although not strictly an open government issue, the articles sheds light on a pervasive problem that affects most Americans and is directly attributable to unchecked industry secrecy.

It is a plea for greater openness and transparency as a means of reigning in rapidly escalating costs.